Palvella Therapeutics Inc (NASDAQ: PVLA) kicked off on Friday, up 7.28% from the previous trading day, before settling in for the closing price of $22.11. Over the past 52 weeks, PVLA has traded in a range of $6.20-$29.27.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
While this was happening, its average annual earnings per share was recorded 61.98%. With a float of $6.55 million, this company’s outstanding shares have now reached $11.02 million.
In terms of profitability, gross margin is 0.0%, operating margin of 0.0%, and the pretax margin is 0.0%.
Palvella Therapeutics Inc (PVLA) Insider Activity
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Palvella Therapeutics Inc is 40.80%, while institutional ownership is 30.26%. The most recent insider transaction that took place on Apr 09 ’25, was worth 50,472. In this transaction Director of this company bought 2,490 shares at a rate of $20.27, taking the stock ownership to the 13,516 shares. Before that another transaction happened on Apr 09 ’25, when Company’s Director bought 2,500 for $20.13, making the entire transaction worth $50,325. This insider now owns 183,171 shares in total.
Palvella Therapeutics Inc (PVLA) Earnings and Forecasts
According to the Wall Street analysts, stocks earnings will be around 61.98% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 18.74% during the next five years compared to 11.57% growth over the previous five years of trading.
Palvella Therapeutics Inc (NASDAQ: PVLA) Trading Performance Indicators
Take a look at Palvella Therapeutics Inc’s (PVLA) current performance indicators. Last quarter, stock had a quick ratio of 8.84. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 194.25.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -12.61, a number that is poised to hit -0.74 in the next quarter and is forecasted to reach -3.23 in one year’s time.
Technical Analysis of Palvella Therapeutics Inc (PVLA)
Analysing the last 5-days average volume posted by the [Palvella Therapeutics Inc, PVLA], we can find that recorded value of 56580.0 was lower than the volume posted last year of 68642.0. As of the previous 9 days, the stock’s Stochastic %D was 64.35%. Additionally, its Average True Range was 2.01.
During the past 100 days, Palvella Therapeutics Inc’s (PVLA) raw stochastic average was set at 69.34%, which indicates a significant decrease from 83.33% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 82.46% in the past 14 days, which was lower than the 87.15% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $24.44, while its 200-day Moving Average is $18.48. Now, the first resistance to watch is $24.75. This is followed by the second major resistance level at $25.79. The third major resistance level sits at $27.18. If the price goes on to break the first support level at $22.32, it is likely to go to the next support level at $20.93. Should the price break the second support level, the third support level stands at $19.89.
Palvella Therapeutics Inc (NASDAQ: PVLA) Key Stats
The company with the Market Capitalisation of 262.24 million has total of 11,056K Shares Outstanding. Its annual sales at the moment are 0 K in contrast with the sum of -17,430 K annual income. Company’s last quarter sales were recorded 0 K and last quarter income was -8,190 K.
